Published in Curr Top Microbiol Immunol on January 01, 1999
Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol (2006) 4.01
Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect Dis (2009) 2.82
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34
In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci U S A (2003) 2.32
Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J (2000) 2.08
Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog (2006) 2.01
Infection and activation of monocytes by Marburg and Ebola viruses. J Virol (2001) 1.90
Filoviruses in bats: current knowledge and future directions. Viruses (2014) 1.79
Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol (2003) 1.78
Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol (2002) 1.71
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother (2006) 1.63
Antibody-dependent enhancement of Ebola virus infection. J Virol (2003) 1.62
Membrane association induces a conformational change in the Ebola virus matrix protein. EMBO J (2000) 1.59
VP24 of Marburg virus influences formation of infectious particles. J Virol (2005) 1.46
Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J Virol (2011) 1.28
RNA polymerase I-driven minigenome system for Ebola viruses. J Virol (2005) 1.27
Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol (2006) 1.26
Association of ebola virus matrix protein VP40 with microtubules. J Virol (2005) 1.18
Detection of Ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein. J Clin Microbiol (2001) 1.09
Role for amino acids 212KLR214 of Ebola virus VP40 in assembly and budding. J Virol (2007) 1.08
Detection of cell-cell fusion mediated by Ebola virus glycoproteins. J Virol (2006) 0.98
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses. J Virol (2015) 0.95
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice. Vaccine (2011) 0.92
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein. J Virol (2015) 0.87
Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum. Virol J (2011) 0.85
Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation. PLoS One (2013) 0.84
Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans. Antiviral Res (2015) 0.78
Cellular factors implicated in filovirus entry. Adv Virol (2013) 0.75
Risks Posed by Reston, the Forgotten Ebolavirus. mSphere (2016) 0.75
Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res (1993) 3.89
Descriptive analysis of Ebola virus proteins. Virology (1985) 2.65
Cytoplasmic compartmentalization of the protein and ribonucleic acid species of vesicular stomatitis virus. J Virol (1972) 2.37
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J Gen Virol (1989) 1.92
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
Ribonucleic acid species of intracellular nucleocapsids and released virions of vesicular stomatitis virus. J Virol (1972) 1.86
Identification and analysis of Ebola virus messenger RNA. Virology (1987) 1.84
Ebola virus: identification of virion structural proteins. J Gen Virol (1980) 1.54
Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses. J Gen Virol (1992) 1.53
The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression. Virology (1989) 1.42
Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Gen Virol (1991) 1.35
The nucleotide sequence of the L gene of Marburg virus, a filovirus: homologies with paramyxoviruses and rhabdoviruses. Virology (1992) 1.32
Hantaan virus: identification of virion proteins. J Gen Virol (1984) 1.27
Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. J Infect Dis (1982) 1.20
Virion nucleic acid of Ebola virus. J Virol (1980) 1.15
Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus. Lancet (1979) 1.14
Evidence for two subtypes of Ebola virus based on oligonucleotide mapping of RNA. J Infect Dis (1983) 1.14
The structure of serotype H10 hemagglutinin of influenza A virus: comparison of an apathogenic avian and a mammalian strain pathogenic for mink. Virology (1988) 1.13
Morphological identification of the agent of Korean haemorrhagic fever (Hantaan virus)as a member of the Bunyaviridae. Lancet (1982) 1.13
Replication of measles virus: distinct species of short nucleocapsids in cytoplasmic extracts of infected cells. J Virol (1974) 1.11
Herpesvirus simiae contamination of primary rhesus monkey kidney cell cultures. CDC recommendations to minimize risks to laboratory personnel. Diagn Microbiol Infect Dis (1990) 1.10
Isolation and characterization of temperature-sensitive mutants of measles virus. J Virol (1975) 1.08
Characterization of influenza virus neuraminidases: peptide changes associated with antigenic divergence between early and late N2 neuraminidases. J Virol (1973) 0.98
Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys. J Med Virol (1992) 0.94
Identification of Ippy as a Lassa-fever-related virus. Lancet (1985) 0.93
Viral haemorrhagic fever surveillance in Kenya, 1980-1981. Trop Geogr Med (1983) 0.91
Genetic variation among Lassa and Lassa-related arenaviruses analysed by T1-oligonucleotide mapping. Ann Inst Pasteur Virol (1989) 0.90
Evolutionary biology of a Lassa virus complex. Med Microbiol Immunol (1986) 0.89
Standardization of a plaque assay for Lassa virus. J Med Virol (1987) 0.84
Replication of measles virus: continued synthesis of nucleocapsid RNA and increased synthesis of mRNA in the presence of cycloheximide. J Virol (1974) 0.82
Serological and biological evidence that Lassa-complex arenaviruses are widely distributed in Africa. Med Microbiol Immunol (1986) 0.82
Components in brain heart infusion selective for chromogenic variants of Staphylococcus aureus. Can J Microbiol (1970) 0.81
Isoelectric focusing studies of A2-1957 influenza neuraminidase and its subunits. Biochim Biophys Acta (1973) 0.80
Ebola protein analyses for the determination of genetic organization. Arch Virol (1993) 0.77
Comparative studies of wild-type and "cold-mutant" (temperature-sensitive) influenza viruses: polypeptide synthesis by an Asian (H2N2) strain and its cold-adapted variant. J Virol (1973) 0.75
Development of an immunofluorescence focus assay for Ebola virus. J Clin Microbiol (1983) 0.75
Evidence of precursors of defective measles virus. Med Microbiol Immunol (1974) 0.75
Comparative analysis of the structural polypeptides of Ebola viruses from Sudan and Zaire. J Infect Dis (1983) 0.75
Conservation of the 3' terminal nucleotide sequences of Ebola and Marburg virus. Virology (1986) 0.75